Evidence map›Paper›PMID 37855394›Full record

ArticleInternational journal of cancer2024

The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E

Ge Sun, Harriett Fuller, Hayley Fenton, Amanda D Race, Amy Downing, Elizabeth A Williams, Colin J Rees, Louise C Brown, Paul M Loadman, Mark A Hull

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ge SunLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
Harriett FullerLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
Hayley FentonLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
Amanda D RaceInstitute of Cancer Therapeutics, University of Bradford, Bradford, UK.
Amy DowningLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
Elizabeth A WilliamsSchool of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Colin J ReesPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Louise C BrownMRC Clinical Trials Unit at University College, London, UK.
Paul M LoadmanInstitute of Cancer Therapeutics, University of Bradford, Bradford, UK.
Mark A HullLeeds Institute of Medical Research, University of Leeds, Leeds, UK.ORCID 0000-0001-7414-1576
University of Leeds · GBUniversity of Bradford · GBMRC Clinical Trials Unit at UCL · GBNewcastle University · GBUniversity of Sheffield · GB

Funding

Cancer Research UK C23434/A24939
6 · The paper itself

Abstract

Urinary prostaglandin (PG) E metabolite (PGE-M) and 11-dehydro (d)-thromboxane (TX) B

Indexed as

AspirinColonic PolypsBiomarkersEicosapentaenoic AcidHumansPlatelet ActivationProstaglandin-Endoperoxide SynthasesProstaglandinsThromboxane B2AspirinBiomarkersEicosapentaenoic AcidProstaglandin-Endoperoxide SynthasesProstaglandinsThromboxane B2aspirincolorectal cancereicosapentaenoic acidprostaglandinthromboxane

Identifiers

PMID37855394
PMCPMC10952676
OpenAlexW4387764665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.